Hepatitis C virus genotypes and subtypes circulating in Mainland China

References

• Mohd Hanafiah K, Groeger J, Flaxman ADet al.Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013;57: 1333–1342.
   PubMed Web of Science ®Google Scholar
• Cui Y, Jia J.Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol 2013;28 (Suppl 1): 7–10.
   PubMed Web of Science ®Google Scholar
• Messina JP, Humphreys I, Flaxman Aet al.Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015;61: 77–87.
   PubMed Web of Science ®Google Scholar
• Aceijas C, Rhodes T.Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007;18: 352–358.
   PubMed Web of Science ®Google Scholar
• Cuypers L, Ceccherini-Silberstein F, Van Laethem Ket al.Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time. Rev Med Virol 2016;26: 408–434.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Hepatology CSoID.[Guidelines for prevention and therapy for hepatitis C]. Chin J Exp Clin Infect Dis 2015;9: 590–607.
   Google Scholar
• Fu Y, Wang Y, Xia Wet al.New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Viral Hepat 2011;18: 42–52.
   PubMed Web of Science ®Google Scholar
• Murphy DG, Sablon E, Chamberland Jet al.Hepatitis C virus genotype 7, a new genotype originating from central Africa. J Clin Microbiol 2015;53: 967–972.
   PubMed Web of Science ®Google Scholar
• Yan Z, Fan K, Wang Yet al.Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china. Hepat Mon 2012;12: 196–204.
   PubMed Web of Science ®Google Scholar
• Bao YP, Liu ZM, Lian Zet al.Prevalence and correlates of HIV and HCV infection among amphetamine-type stimulant users in 6 provinces in China. J Acquir Immune Defic Syndr 2012;60: 438–446.
   PubMed Web of Science ®Google Scholar
• Rao H, Wei L, Lopez-Talavera JCet al.Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2014;29: 545–553.
   PubMed Web of Science ®Google Scholar
• Ray SC, Mao Q, Lanford REet al.Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol 2000;74: 3058–3066.
   PubMed Web of Science ®Google Scholar
• Ray SC, Arthur RR, Carella Aet al.Genetic epidemiology of hepatitis C virus throughout egypt. J Infect Dis 2000;182: 698–707.
   PubMed Web of Science ®Google Scholar
• Li Q, Yao Y, Shen Yet al.Assessment of HCV genotypes in Yunnan Province of Southwest China. Virus genes 2017;53: 190–196.
   PubMed Web of Science ®Google Scholar
• Westbrook RH, Dusheiko G.Natural history of hepatitis C. J Hepatol 2014;61 (1 Suppl): S58–S68.
   PubMed Web of Science ®Google Scholar
• Gower E, Estes C, Blach Set al.Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014;61 (1 Suppl): S45–S57.
   PubMed Web of Science ®Google Scholar
• Mao XR, Zhang LT, Jiang Net al.[Distribution of HCV genotypes in Chinese Han population with chronic hepatitis C]. Zhejiang Da Xue Xue Bao Yi Xue Ban 2015;44: 417–422.
   PubMedGoogle Scholar
• Doi H, Apichartpiyakul C, Ohba KIet al.Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 1996;34: 569–574.
   PubMed Web of Science ®Google Scholar
• Ruta S, Cernescu C.Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes. World J Gastroenterol 2015;21: 10811–10823.
   PubMed Web of Science ®Google Scholar
• Ju W, Yang S, Feng Set al.Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6. Virol J 2015;12: 109.
   PubMed Web of Science ®Google Scholar
• Li C, Barnes E, Newton PNet al.An expanded taxonomy of hepatitis C virus genotype 6: Characterization of 22 new full-length viral genomes. Virology 2015;476: 355–363.
   PubMed Web of Science ®Google Scholar
• Dashan Hu WZ, Xue R, Li H.[Analysis on genotype and route of infection for 215 Hepatitis C cases in Nanjing and Guangdong areas]. Jiangsu Med J 2014;40: 597–598.
   Google Scholar
• Gammal RS, Spooner LM, Abraham GM.Failed triple therapy in a treatment-experienced patient with genotype 6 hepatitis C infection. Am J Health Syst Pharm 2014;71: 204–208.
   PubMed Web of Science ®Google Scholar
• Cai Q, Zhao Z, Liu Yet al.Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay. Int J Mol Med 2013;31: 347–352.
   PubMed Web of Science ®Google Scholar
• Tao Wu HL, Xiong L, Wang Jet al.[Application of PCR fluorescent probe in identifying genotypes of HCV]. Chinese Journal of Clinical Infectious Diseases 2017;10: 37–42.
   Google Scholar
• European Association for Study of L.EASL Recommendations on Treatment of Hepatitis C 2015. J Hepatol 2015;63: 199–236.
   Google Scholar
• Wedemeyer H, Duberg AS, Buti Met al.Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014;21 (Suppl 1): 60–89.
   PubMed Web of Science ®Google Scholar
• Zeuzem S, Jacobson IM, Baykal Tet al.Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. N Engl J Med 2014;370: 1604–1614.
   PubMed Web of Science ®Google Scholar
• Feld JJ, Kowdley KV, Coakley Eet al.Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. N Engl J Med 2014;370: 1594–1603.
   PubMed Web of Science ®Google Scholar
• Hezode C, Asselah T, Reddy KRet al.Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial. Lancet 2015;385: 2502–2509.
   PubMed Web of Science ®Google Scholar
• Hsu CS.Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 2013;369: 678.
   PubMed Web of Science ®Google Scholar
• Zeuzem S, Dusheiko GM, Salupere Ret al.Sofosbuvir and ribavirin in HCV genotypes 2 and 3. N Engl J Med 2014;370: 1993–2001.
   PubMed Web of Science ®Google Scholar
• Gane EJ, Hyland RH, An Det al.Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection. Gastroenterology 2015;149: 1454–1461. e1451.
   PubMed Web of Science ®Google Scholar